Posts tagged: NX-1207

Nymox Pharmaceuticals gets $15M financing deal

Tweet Drug developer Nymox Pharmaceutical Corp. said Thursday it has obtained a commitment for $15 million in equity financing from institutional investors. The money will be used for general corporate purposes. The financing also will help the company continue with research into new drugs including one called NX-1207, which may treat an enlarged prostate. The investors may get common stock at a 3 percent discount to the market price, the company ... Jump to full article >>